Startup Showcase: Gandeeva Therapeutics – Revolutionizing Therapeutic Development

Unveiling the Future of Precision Biotechnology.

As the world of healthcare and medicine continues to evolve, innovative startups are making groundbreaking advancements in the field. In this Startup Showcase, we present Gandeeva Therapeutics, a precision biotechnology company based in Vancouver, British Columbia, Canada. With their cutting-edge approach combining cryogenic electron microscopy (cryo-EM) and machine learning, Gandeeva Therapeutics is revolutionizing therapeutic development, aiming to provide better treatment options for patients.

Pioneering Precision Medicine with Cryo-EM and Machine Learning

Gandeeva Therapeutics harnesses the power of cryo-EM and computational tools to drive their research and development efforts. By leveraging cryo-EM, a technique that allows for high-resolution imaging of biological macromolecules, Gandeeva gains valuable insights into the structures and interactions of proteins within the body. These insights serve as a foundation for developing targeted therapies that can effectively modulate key protein-protein interactions.

Empowering Drug Discovery with Innovative Platforms

At the core of Gandeeva’s success lies their proprietary structure-guided drug discovery platform. This platform comprises three key components: SPOTLIGHT™, HYPERFOCUS™, and CRYO-CADD™. SPOTLIGHT™ focuses on target prediction and validation, ensuring the identification of suitable protein targets for therapeutic intervention. HYPERFOCUS™ employs virtual and fragment library screening to identify potential hits for drug development. Finally, CRYO-CADD™ optimizes and refines the lead compounds, streamlining the process of bringing effective treatments to patients.

A Promising Pipeline Targeting Difficult-to-Treat Cancers

Gandeeva Therapeutics has established a robust preclinical oncology pipeline that specifically targets challenging and hard-to-treat cancers. By developing novel protein interaction modulators like interfacial glues (iGlues™) and allosteric inhibitors, Gandeeva aims to overcome the limitations of traditional therapies. These innovative approaches hold great promise in improving patient outcomes and revolutionizing cancer treatment strategies.

Headquartered in Vancouver, Innovating Globally

With their headquarters located in the Greater Vancouver area, Gandeeva Therapeutics operates at the forefront of biotechnology innovation in Canada. However, their impact extends far beyond national boundaries. By collaborating with global partners and attracting top talent, Gandeeva strives to accelerate the pace of therapeutic development and provide hope to patients worldwide.


Gandeeva Therapeutics stands as a beacon of hope in the biotechnology landscape, combining cutting-edge technologies with a deep understanding of protein interactions. By harnessing the power of cryo-EM and machine learning, Gandeeva is on a mission to transform the way we approach therapeutic development. Their precision biotechnology platform and innovative pipeline offer new possibilities in treating challenging diseases, particularly in the realm of oncology.


Looking to amplify your brand’s impact in Canada’s thriving startup and investment sector? Join the league of innovators, leaders, and decision-makers making a difference through Canada Venture News. Engage with our audience of startup founders, investors, and executives through sponsored articles and partnerships. Discover more on our Promotion & Sponsored Articles page or email us directly at [email protected]. Let’s shape your story together.

Canada Venture News is a Canadian venture magazine that covers startups, business, technology, and innovation in Canada. The online publication provides news, insights, and resources for entrepreneurs, investors, and business professionals, featuring articles, interviews, and analysis of the latest trends and developments in the Canadian startup ecosystem.